Elvitegravir CsA 271

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 effect

Not reported

Drug 2
Clinical Effects

Potential for increased cyclosporine toxicity

Management

If coadministering, initiate lower dose of immunosuppressant, therapeutic drug monitoring is recommended, assess toxicity, consult with specialist, and adjust dose as necessary

Import ID
271